Logo image of MND.CA

MANDALAY RESOURCES CORP (MND.CA) Stock Fundamental Analysis

TSX:MND - Toronto Stock Exchange - CA5625684025 - Common Stock - Currency: CAD

4.68  0 (0%)

Fundamental Rating

7

Overall MND gets a fundamental rating of 7 out of 10. We evaluated MND against 832 industry peers in the Metals & Mining industry. MND scores excellent points on both the profitability and health parts. This is a solid base for a good stock. A decent growth rate in combination with a cheap valuation! Better keep an eye on MND. These ratings could make MND a good candidate for value and quality investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year MND was profitable.
MND had a positive operating cash flow in the past year.
MND had positive earnings in 4 of the past 5 years.
MND had a positive operating cash flow in each of the past 5 years.
MND.CA Yearly Net Income VS EBIT VS OCF VS FCFMND.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M

1.2 Ratios

MND's Return On Assets of 9.21% is amongst the best of the industry. MND outperforms 93.44% of its industry peers.
The Return On Equity of MND (13.10%) is better than 93.84% of its industry peers.
The Return On Invested Capital of MND (13.66%) is better than 96.39% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MND is in line with the industry average of 11.94%.
The 3 year average ROIC (10.28%) for MND is below the current ROIC(13.66%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.21%
ROE 13.1%
ROIC 13.66%
ROA(3y)9.42%
ROA(5y)4.83%
ROE(3y)15.94%
ROE(5y)7.61%
ROIC(3y)10.28%
ROIC(5y)N/A
MND.CA Yearly ROA, ROE, ROICMND.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60

1.3 Margins

MND has a better Profit Margin (13.28%) than 94.51% of its industry peers.
MND's Profit Margin has declined in the last couple of years.
MND's Operating Margin of 29.27% is amongst the best of the industry. MND outperforms 95.98% of its industry peers.
MND's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 36.09%, MND belongs to the best of the industry, outperforming 93.31% of the companies in the same industry.
In the last couple of years the Gross Margin of MND has declined.
Industry RankSector Rank
OM 29.27%
PM (TTM) 13.28%
GM 36.09%
OM growth 3Y-28.34%
OM growth 5YN/A
PM growth 3Y-4.43%
PM growth 5YN/A
GM growth 3Y-18.1%
GM growth 5YN/A
MND.CA Yearly Profit, Operating, Gross MarginsMND.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

7

2. Health

2.1 Basic Checks

MND has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
MND has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, MND has more shares outstanding
The debt/assets ratio for MND has been reduced compared to a year ago.
MND.CA Yearly Shares OutstandingMND.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
MND.CA Yearly Total Debt VS Total AssetsMND.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

An Altman-Z score of 3.66 indicates that MND is not in any danger for bankruptcy at the moment.
MND has a better Altman-Z score (3.66) than 63.05% of its industry peers.
MND has a debt to FCF ratio of 0.16. This is a very positive value and a sign of high solvency as it would only need 0.16 years to pay back of all of its debts.
MND has a Debt to FCF ratio of 0.16. This is amongst the best in the industry. MND outperforms 96.12% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that MND is not too dependend on debt financing.
MND has a Debt to Equity ratio of 0.02. This is comparable to the rest of the industry: MND outperforms 41.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.16
Altman-Z 3.66
ROIC/WACC1.42
WACC9.61%
MND.CA Yearly LT Debt VS Equity VS FCFMND.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 2.00 indicates that MND has no problem at all paying its short term obligations.
MND has a Current ratio of 2.00. This is comparable to the rest of the industry: MND outperforms 52.61% of its industry peers.
MND has a Quick Ratio of 1.48. This is a normal value and indicates that MND is financially healthy and should not expect problems in meeting its short term obligations.
MND has a Quick ratio of 1.48. This is comparable to the rest of the industry: MND outperforms 48.33% of its industry peers.
Industry RankSector Rank
Current Ratio 2
Quick Ratio 1.48
MND.CA Yearly Current Assets VS Current LiabilitesMND.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 462.50% over the past year.
MND shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -31.90% yearly.
MND shows a strong growth in Revenue. In the last year, the Revenue has grown by 36.74%.
The Revenue has been growing by 9.09% on average over the past years. This is quite good.
EPS 1Y (TTM)462.5%
EPS 3Y-31.9%
EPS 5YN/A
EPS Q2Q%175%
Revenue 1Y (TTM)36.74%
Revenue growth 3Y-1.06%
Revenue growth 5Y9.09%
Sales Q2Q%35.16%

3.2 Future

The Earnings Per Share is expected to grow by 42.58% on average over the next years. This is a very strong growth
Based on estimates for the next years, MND will show a small growth in Revenue. The Revenue will grow by 1.78% on average per year.
EPS Next Y358.71%
EPS Next 2Y94.62%
EPS Next 3Y73.45%
EPS Next 5Y42.58%
Revenue Next Year33.44%
Revenue Next 2Y15.03%
Revenue Next 3Y13.29%
Revenue Next 5Y1.78%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MND.CA Yearly Revenue VS EstimatesMND.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M 250M
MND.CA Yearly EPS VS EstimatesMND.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 -1

10

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 7.20, the valuation of MND can be described as very cheap.
Based on the Price/Earnings ratio, MND is valued cheaply inside the industry as 95.31% of the companies are valued more expensively.
MND's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.12.
A Price/Forward Earnings ratio of 7.18 indicates a rather cheap valuation of MND.
95.05% of the companies in the same industry are more expensive than MND, based on the Price/Forward Earnings ratio.
MND's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 94.77.
Industry RankSector Rank
PE 7.2
Fwd PE 7.18
MND.CA Price Earnings VS Forward Price EarningsMND.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MND is valued cheaper than 98.39% of the companies in the same industry.
MND's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MND is cheaper than 97.46% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.24
EV/EBITDA 2.42
MND.CA Per share dataMND.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

MND's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of MND may justify a higher PE ratio.
A more expensive valuation may be justified as MND's earnings are expected to grow with 73.45% in the coming years.
PEG (NY)0.02
PEG (5Y)N/A
EPS Next 2Y94.62%
EPS Next 3Y73.45%

0

5. Dividend

5.1 Amount

No dividends for MND!.
Industry RankSector Rank
Dividend Yield N/A

MANDALAY RESOURCES CORP

TSX:MND (2/7/2025, 7:00:00 PM)

4.68

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)02-20 2025-02-20/amc
Inst Owners52.13%
Inst Owner ChangeN/A
Ins Owners1.72%
Ins Owner ChangeN/A
Market Cap435.71M
Analysts80
Price Target5.87 (25.43%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.1
Dividend Growth(5Y)-0.73%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)98.02%
Min EPS beat(2)78.22%
Max EPS beat(2)117.82%
EPS beat(4)3
Avg EPS beat(4)41.36%
Min EPS beat(4)-40.59%
Max EPS beat(4)117.82%
EPS beat(8)5
Avg EPS beat(8)-3.53%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)10.08%
Min Revenue beat(2)-2.25%
Max Revenue beat(2)22.41%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)4.55%
EPS NQ rev (1m)50%
EPS NQ rev (3m)90.91%
EPS NY rev (1m)5.83%
EPS NY rev (3m)9%
Revenue NQ rev (1m)4.69%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.94%
Revenue NY rev (3m)-1.27%
Valuation
Industry RankSector Rank
PE 7.2
Fwd PE 7.18
P/S 1.35
P/FCF 6.24
P/OCF 3.41
P/B 1.33
P/tB 1.33
EV/EBITDA 2.42
EPS(TTM)0.65
EY13.89%
EPS(NY)0.65
Fwd EY13.93%
FCF(TTM)0.75
FCFY16.02%
OCF(TTM)1.37
OCFY29.33%
SpS3.46
BVpS3.51
TBVpS3.51
PEG (NY)0.02
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.21%
ROE 13.1%
ROCE 24.32%
ROIC 13.66%
ROICexc 17.21%
ROICexgc 17.21%
OM 29.27%
PM (TTM) 13.28%
GM 36.09%
FCFM 21.67%
ROA(3y)9.42%
ROA(5y)4.83%
ROE(3y)15.94%
ROE(5y)7.61%
ROIC(3y)10.28%
ROIC(5y)N/A
ROICexc(3y)12.05%
ROICexc(5y)N/A
ROICexgc(3y)12.05%
ROICexgc(5y)N/A
ROCE(3y)18.29%
ROCE(5y)N/A
ROICexcg growth 3Y-33.59%
ROICexcg growth 5YN/A
ROICexc growth 3Y-33.59%
ROICexc growth 5YN/A
OM growth 3Y-28.34%
OM growth 5YN/A
PM growth 3Y-4.43%
PM growth 5YN/A
GM growth 3Y-18.1%
GM growth 5YN/A
F-Score9
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.16
Debt/EBITDA 0.05
Cap/Depr 102.33%
Cap/Sales 18.01%
Interest Coverage 41.55
Cash Conversion 84.67%
Profit Quality 163.15%
Current Ratio 2
Quick Ratio 1.48
Altman-Z 3.66
F-Score9
WACC9.61%
ROIC/WACC1.42
Cap/Depr(3y)122.72%
Cap/Depr(5y)127.81%
Cap/Sales(3y)21.91%
Cap/Sales(5y)24.8%
Profit Quality(3y)72.3%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)462.5%
EPS 3Y-31.9%
EPS 5YN/A
EPS Q2Q%175%
EPS Next Y358.71%
EPS Next 2Y94.62%
EPS Next 3Y73.45%
EPS Next 5Y42.58%
Revenue 1Y (TTM)36.74%
Revenue growth 3Y-1.06%
Revenue growth 5Y9.09%
Sales Q2Q%35.16%
Revenue Next Year33.44%
Revenue Next 2Y15.03%
Revenue Next 3Y13.29%
Revenue Next 5Y1.78%
EBIT growth 1Y217.49%
EBIT growth 3Y-29.11%
EBIT growth 5YN/A
EBIT Next Year366.27%
EBIT Next 3Y65.83%
EBIT Next 5Y38.72%
FCF growth 1Y32.6%
FCF growth 3Y-54.7%
FCF growth 5YN/A
OCF growth 1Y16.08%
OCF growth 3Y-11.12%
OCF growth 5Y17.17%